This workgroup will assess the feasibility of using the tree-based scan statistic routinely in a drug setting. An appropriate exposure (i.e. short-term, fixed-length) will be selected to test the use with self-controlled tree-temporal scan statistic.
Judith C. Maro, PhD; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
Elande Baro, PhD, MS; Rima Izem, PhD; Michael Nguyen, MD; Jacqueline Puigbo, PhD, MS; Esther Zhou, MD, PhD; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
David Cole, BM; Meighan Rogers Driscoll, MPH; Austin Cosgrove, BS; Inna Dashevsky, MS; Megan Reidy, MPH; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
Joshua J. Gagne, PharmD, ScD; Martin Kulldorff, PhD; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA